Pages that link to "Q33372680"
Jump to navigation
Jump to search
The following pages link to Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses (Q33372680):
Displaying 50 items.
- Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm? (Q21090716) (← links)
- Effect of domperidone on insufficient lactation in puerperal women: a systematic review and meta-analysis of randomized controlled trials (Q21285009) (← links)
- Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) (Q22061981) (← links)
- Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis (Q22241119) (← links)
- Dipeptidyl-peptidase (DPP)-4 inhibitors or glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus (Q24185805) (← links)
- Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus (Q24185874) (← links)
- Thrombolysis for acute upper extremity deep vein thrombosis (Q24185948) (← links)
- Continued lamivudine for adults with lamivudine-resistant chronic hepatitis B virus infection (Q24185958) (← links)
- Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus (Q24185970) (← links)
- Interferon for people with lamivudine-resistant chronic hepatitis B virus infection (Q24185973) (← links)
- Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for development of type 2 diabetes mellitus (Q24186087) (← links)
- Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma (Q24186130) (← links)
- Antithrombin III for critically ill patients (Q24186159) (← links)
- Deliberate hypotension for orthopaedic surgery (Q24186196) (← links)
- Selenium supplementation for critically ill adults (Q24186311) (← links)
- Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma (Q24186496) (← links)
- Prolonged storage of packed red blood cells for blood transfusion (Q24186513) (← links)
- Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients (Q24186523) (← links)
- Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis (Q24186554) (← links)
- Homocysteine-lowering interventions for preventing cardiovascular events (Q24186605) (← links)
- Non-invasive positive pressure ventilation for acute asthma in children (Q24186648) (← links)
- Sulphonylurea monotherapy for patients with type 2 diabetes mellitus (Q24186660) (← links)
- Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus (Q24186667) (← links)
- Non-acute percutaneous coronary intervention versus medical therapy in patients with ischaemic heart disease (Q24186673) (← links)
- Pharmacotherapy for hypertension-induced left ventricular hypertrophy (Q24186750) (← links)
- Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users (Q24186909) (← links)
- The effects of high perioperative inspiratory oxygen fraction for adult surgical patients (Q24187017) (← links)
- Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients (Q24187112) (← links)
- Antibiotic prophylaxis for surgical site infection in people undergoing liver transplantation (Q24187200) (← links)
- Vitamin K for upper gastrointestinal bleeding in people with acute or chronic liver diseases (Q24187239) (← links)
- Antifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver disease (Q24187246) (← links)
- Interventions for treating intrahepatic cholestasis in people with sickle cell disease (Q24187279) (← links)
- Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage (Q24187528) (← links)
- Adefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infection (Q24187530) (← links)
- Acetyl-L-carnitine for patients with hepatic encephalopathy (Q24187553) (← links)
- Gemcitabine-based chemotherapy for advanced biliary tract carcinomas (Q24187573) (← links)
- Nutrition support in hospitalised adults at nutritional risk (Q24187602) (← links)
- Rifaximin for people with hepatic encephalopathy (Q24187627) (← links)
- Interferon alpha versus any other drug for chronic hepatitis D (Q24187640) (← links)
- Drug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinoma (Q24187663) (← links)
- Tyrosine kinase inhibitors for unresectable hepatocellular carcinoma in adults (Q24187730) (← links)
- Prophylactic lidocaine for myocardial infarction (Q24187816) (← links)
- Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension (Q24187969) (← links)
- Surgical portosystemic shunts versus devascularisation procedures for variceal bleeding due to hepatosplenic schistosomiasis (Q24188170) (← links)
- Antibiotic therapy for adults with neurosyphilis (Q24188209) (← links)
- S-adenosyl-L-methionine for people with alcoholic liver disease (Q24188235) (← links)
- Terlipressin versus other vasoactive drugs for hepatorenal syndrome (Q24188350) (← links)
- Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria (Q24193045) (← links)
- Vitamin D supplementation for prevention of cancer in adults (Q24193850) (← links)
- Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma (Q24194017) (← links)